与MMPs相关的风险模型识别和SAA1通过ERK-AP1-MMPs轴促进清细胞细胞癌的迁移
Haotian Wei1, Yajun Li1, Jian Zhang2
1Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Scientific reports
|April 24, 2024
概括
矩阵金属蛋白酶 (MMPs) 是清除细胞细胞癌 (ccRCC) 转移的关键. 这项研究确定了MMPs作为预后标志物,并揭示了SAA1的SAA1.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 矩阵金属蛋白酶 (MMPs) 与清细胞细胞癌 (ccRCC) 的迁移和转移有关.
- 在预测ccRCC临床结果和指导治疗方面,MMPs的确切作用尚未完全理解.
研究的目的:
- 调查ccRCC中MMP家族的临床意义和预后价值.
- 阐明MMP对ccRCC进展的贡献背后的机制.
- 开发基于MMPs的ccRCC患者的新型预后模型.
主要方法:
- 对MMP家族的泛癌分析.
- 在ccRCC中对MMP的临床价值评估和机制分析.
- 使用MMPs开发分层方法和预后模型.
- 多态和转录调节分析.
- 在体外实验验证SAA1的作用.
主要成果:
- 与其他癌症相比,MMP在ccRCC中具有明显的意义.
- 开发了一种基于MMP的新型预后模型,以改善ccRCC预后预测.
- 通过ERK-AP1-MMPs轴,SAA1被确定为ccRCC迁移的关键推动者.
结论:
- MMP家族具有作为ccRCC的预后标志物和治疗指南的潜力.
- SAA1是ccRCC细胞迁移的关键因素,通过ERK-AP1-MMPs途径起作用.
- 这项研究为ccRCC患者提供了个性化的治疗策略.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


